ReviewDialogues in clinical neuroscience2020
The costs and benefits of cannabis control policies .
Review in Dialogues in clinical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The clouded debate: A systematic review of comparative longitudinal studies examining the impact of recreational cannabis legalization on key public health outcomes.Frontiers in psychiatry · 2022Pooled it
- Racial and Ethnic Differences in Suicide Mortality Among Youth Aged 12-25 Years Following Medical and Recreational Cannabis Legalization in the U.S.American journal of preventive medicine · 2026Article
- Post-legalization shifts in cannabis use among young adults in Georgia-A nationally representative study.Addiction (Abingdon, England) · 2025Article
- Adolescents' perceptions, experiences, and reactions to "fake" vaping devices.Drug and alcohol dependence · 2025Article
- Internet, App-Based, and Casino Gambling: Associations Between Modality, Problem Gambling, and Substance Use.Journal of gambling studies · 2024Article
- Navigating the Grey Zone: The Impact of Legislative Frameworks in North America and Europe on Adolescent Cannabis Use-A Systematic Review.Behavioral sciences (Basel, Switzerland) · 2024Review
- Cannabis use among adolescents and young adults during the COVID-19 pandemic: A systematic review.Drug and alcohol dependence reports · 2024Review
- Current Status of Cannabis Legalization and Decriminalization Efforts in Nepal.Substance abuse and rehabilitation · 2024Article
- Cannabis and Alcohol Use by U.S. Young Adults, 2008-2019: Changes in Prevalence After Recreational Cannabis Legalization.American journal of preventive medicine · 2023Article
- Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency.Addiction (Abingdon, England) · 2023Article
- Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach.Pharmaceutics · 2023Article
- Medicinal and economic benefits of legalization of marijuana in Pakistan.EXCLI journal · 2022Article
- Minimizing policy-biased appraisals of the evidence on cannabis and psychosis.Frontiers in psychiatry · 2022Article
- Article
- Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.Molecules (Basel, Switzerland) · 2021Review
- Cannabis and Psychosis: Weeding Out Fact from Fiction.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As is the case for most drugs, cannabis use has costs and benefits, and so do the policies that attempt to minimize the first and maximize the second. This article summarizes what we know about the harmful effects of recreational cannabis use and the benefits of medical cannabis use under the policy of prohibition that prevailed in developed countries until 2012. It outlines three broad ways in which cannabis prohibition may be relaxed, namely, the depenalization of personal possession and use, the legalization of medical use, and the legalization of adult recreational use. It reviews evidence to date on the impacts of each of these forms of liberalization on the costs and benefits of cannabis use. It makes some plausible conjectures about the future impacts of the commercialization of cannabis using experience from the commercialization of the alcohol, tobacco, and gambling industries. Cannabis policy entails unavoidable trade-offs between competing social values in the face of considerable uncertainty about the effects that more liberal cannabis policies will have on cannabis use and its consequences for better or worse. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.